Taş A, Baloğlu M
Department of Neurosurgery, Medical Faculty, Dicle University, Diyarbakır, Turkey.
Eur Rev Med Pharmacol Sci. 2023 Jul;27(14):6901-6910. doi: 10.26355/eurrev_202307_33162.
This study aimed to investigate the prevalence of pain symptoms in outpatients with COVID-19 and to analyze the relationship between pain-related, psychological, and cognitive variables in patients with ongoing pain complaints after COVID-19.
79 people participated in the research. The focus was on completed demographics (such as age, height, and weight), pain-related (duration and intensity of pain), Modified Medical Research Council (MMRC) Dyspnea Score, and visual analogue scale (VAS) variables.
Significant changes were found in some of the post-COVID symptoms after 3 months. From the 3rd month, the VAS pain scale score, EQ-5D-3L quality of life score, and VAS score obtained from EQ-5D-3L quality of life scale, sitting scores decreased compared to the first measurements. Muscle strength, moderate activity, walking, and total scores increased from the third month.
We suggest physical pain and inactivity symptoms in patients with COVID regressed in the 3rd month.
本研究旨在调查新冠病毒病（COVID-19）门诊患者疼痛症状的患病率，并分析COVID-19后仍有疼痛主诉患者的疼痛相关、心理和认知变量之间的关系。
79人参与了该研究。重点关注完整的人口统计学数据（如年龄、身高和体重）、疼痛相关数据（疼痛持续时间和强度）、改良医学研究委员会（MMRC）呼吸困难评分以及视觉模拟量表（VAS）变量。
3个月后，部分新冠病毒病后症状出现显著变化。从第3个月起，VAS疼痛量表评分、EQ-5D-3L生活质量评分以及从EQ-5D-3L生活质量量表获得的VAS评分、坐位评分与首次测量相比有所下降。肌肉力量、适度活动、步行和总分从第3个月起有所增加。
我们认为新冠病毒病患者的身体疼痛和活动减少症状在第3个月有所缓解。
